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Abstract
Background—Barrett’s esophagus (BE), the premalignant lesion of esophageal
adenocarcinoma, is believed to develop as a result of chronic gastroesophageal reflux disease
(GERD). Approximately 10% of subjects with GERD progress to BE. Genetic, epigenetic and
other risk factors may contribute to this inter-individual variability. Caudal type homeobox 1
(Cdx1) and Caudal type homeobox 2 (Cdx2) play important regulatory roles in the development of
human BE.
Aims—To determine associations between Cdx1 and Cdx2 SNPs and BE
Methods—Genomic DNA was extracted from blood samples collected from BE (n = 109) and
GERD (n = 223) patients for genotyping of 5 single nucleotide polymorphisms (SNPs) each of
Cdx1 and Cdx2 using TaqMan allelic discrimination assays. Odds ratios (OR) and 95% confidence
intervals (CI) of SNPs and haplotypes were calculated with a logistic regression model adjusted
for factors including age, sex and hiatal hernia. Interactions between genetic variants and these
three risk factors were also analyzed.
Results—Older age ( 50 years), male sex and hiatal hernia were significantly associated with BE
(P < 0.001). Five variants of Cdx1 SNPs (rs3776082, rs717746 and rs3776083), one Cdx1
haplotype, and three variants of Cdx2 SNPs (rs4769585 and rs3812863) were associated with BE
(P < 0.05). Statistically significant interactions were detected between most of these SNPs and the
three risk factors (P < 0.05).
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Conclusion—Certain SNPs of Cdx1 and Cdx2 and their interactions with other risk factors are
associated with BE, and may contribute to human susceptibility to BE.
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Introduction
Patients with chronic gastroesophageal reflux disease (GERD) are at a high risk for the
development of Barrett’s esophagus (BE), which is the premalignant lesion of esophageal
adenocarcinoma defined by the presence of endoscopically evident, intestinalized columnar
epithelium in the esophagus. Previous studies reported that approximately 10% of subjects
with GERD progress to BE [1, 2]. Although it is not clear why some individuals are
susceptible to BE, there is increasing evidence to suggest that genetic factors play critical
roles in the development of BE. BE tends to cluster in families and identical twins [3]. Using
genomic linkage analysis, a number of studies have found several genomic regions or
positional candidate genes associated with BE, such as MSR1, ASCC1 and CTHRC1 [4].
Variants of functional candidate genes have also been significantly associated with BE,
including IL-10 [5], GSTP1 [6] and IGF1 [7].
As members of the Caudal-related homeobox gene family, Cdx1 and Cdx2 are important for
intestinal development. Since BE is characterized by intestinal differentiation, it is believed
that Cdx1 and/or Cdx2 are essential for the development of BE [8]. Cdx2 is not expressed in
squamous epithelial cells of normal human esophagus, whereas it is expressed in both goblet
and non-goblet cells of human BE [9]. In vitro studies show that Cdx2 is activated in
esophageal keratinocytes by acid or bile acids [10]. Cdx1 is preceded by Cdx2 during
metaplastic conversion [11]. Transgenic overexpression of Cdx1 or Cdx2 induces intestinal
metaplasia in the transgenic mouse stomach, though with slightly different phenotypes [12].
It is believed that Cdx1 and Cdx2 have mostly overlapping, but also certain distinct,
functions.
A recent study reported that acid and bile salts induced Cdx2 expression in the esophageal
squamous cells obtained from BE, but not in those obtained from GERD without BE [13].
These data suggested that genetic variations of Cdx2 may contribute to gene expression and
thus susceptibility to BE. To date, no study has investigated the association of Cdx1 and
Cdx2 variants with BE. Single nucleotide polymorphism (SNP) is a DNA sequence variation
occurring when a single nucleotide in the genome differs between individuals in a
population. In addition, a set of SNPs may associate with each other to be inherited together
as a haplotype. Both SNPs and haplotypes may impact gene expression and function, and
therefore underlie differences in our susceptibility to disease [14]. This pilot study was
aimed to determine associations of the SNPs and haplotypes of these two intestinal genes
with BE, and their interactions with sex, age and hiatal hernia.
Materials and Methods
Study subjects and recruitment
BE and GERD subjects were recruited at the University of North Carolina (UNC) Hospitals
between June 2002 and January 2008. For inclusion, participants had to have BE with either
no dysplasia or a single past transient reading of low-grade dysplasia (LGD). BE was
defined as any endoscopically detectable upward displacement of the squamocolumnar
junction in the tubular esophagus of greater than 5mm, with at least one biopsy specimen
from the area demonstrating specialized columnar epithelium with goblet cells on routine
Ren et al. Page 2













pathology specimens. Subjects with goblet cells on biopsy, but no endoscopic appearance of
BE, were not eligible for inclusion. Transient LGD was defined as a reading of LGD on a
single biopsy specimen, with at least one subsequent endoscopy negative for dysplasia.
Participants were excluded if they had a history of high-grade dysplasia (HGD) or
adenocarcinoma, endoscopic ablation of BE, esophageal resection, or an active malignancy
(except non-melanoma skin cancer). Erosive esophagitis (EE) was defined as endoscopically
visible mucosal breaks with appreciable depth. Endoscopy-negative reflux disease (ERD)
was diagnosed if patients reported substernal chest burning and/or regurgitation, but
demonstrated no visible esophageal mucosal injury on endoscopy.
Blood samples were obtained for DNA extraction using a FlexiGene DNA Kit (Qiagen,
Valencia, CA). Biopsy specimens were snap-frozen in liquid nitrogen for histopathological
testing. Demographic and clinical information was recorded, including ethnicity, race, age,
sex, hiatal hernia status and endoscopy history. The UNC Institutional Review Board
approved this study.
Selection of SNPs and genotyping
A 10-kb 5′-flanking region of Cdx2 and a 16-kb 5′-flanking region of Cdx1 were scanned for
known SNPs [15, 16]. In addition, to evaluate potential regulatory elements in the 3′UTR, 4
kb downstream of the stop codons of both Cdx1 and Cdx2 were included. All SNPs of Cdx1
and Cdx2 genes were selected from the database of the International HapMap Project (data
release #28). Shannon’s entropy was calculated to evaluate genetic diversity based on the
genotyping data of CEU from HapMap. Entropy-based SNP selection was utilized for
genetic association studies. Final SNP selections were based on relatively high Shannon’s
entropy and genomic positions. In addition, two SNPs (rs9257809 and rs9936833) were
included in this study based on their associations with BE in a recent genome-wide
association study [17].
Genotyping was performed using 5′ nuclease TaqMan assays pre-designed by Applied
Biosystems (Foster City, CA). All TaqMan assay primers of 12 SNPs are available on the
website of the manufacturer (http://www.lifetechnologies.com/us/en/home.html). PCR
reactions in 384-well plates were carried out on the ABI 9700 thermal cycler (Applied
Biosystems) using 5 ng purified DNA as the template. Genotype was detected using an ABI
PRISM 7900 HT Sequence Detection System with SDS 2.3 software (Applied Biosystems).
Statistical analysis
Age, hiatal hernia and sex-corrected odds ratios (ORs), 95% confidence intervals (95% CIs)
and gene-risk factor interactions of SNPs were analyzed by a logistic regression model in
which the homozygous wild-type genotype was used as the reference. The Hardy-Weinberg
equilibrium test, linkage disequilibrium analysis, haplotype analysis and gene-risk factor
interaction analysis were performed online (http://bioinfo.iconcologia.net/snpstats/start.htm)
[17]. A standard Bonferroni correction was used to adjust for multiple testing. The most
frequent haplotype was automatically selected as the reference category, and a global test for
interaction was performed online.
Results
Three hundred and thirty-two Caucasian subjects were recruited, including 109 BE, 31 EE
and 192 ERD subjects. The majority of BE subjects were older than 50 (79.8%), male
(66.1%) and complicated with hiatal hernia (64.2%) (Table 1). EE and ERD were pooled
together as GERD for comparison with BE.
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A 37.63-kb region (chr5:149,510,537 – 149,548,165) and a 21.04-kb region
(chr13:27,430,279 – 27,451,317) were scanned for SNPs in HapMap. Fifty-two Cdx1 SNPs
and 21 Cdx2 SNPs were found. Based on the criteria reviewed above, 10 SNPs were
selected, including 5 SNPs each of Cdx1 and Cdx2 (Table 2). The distribution of genotype
frequencies for the selected SNPs was consistent with Hardy-Weinberg equilibrium in all
subjects (P > 0.05). All SNPs were in linkage disequilibrium except for rs3776083 and
rs3756311 in Cdx1.
Five variants of Cdx1 SNPs (rs3776082, rs717746 and rs3776083) and three variants of
Cdx2 SNPs (rs4769585 and rs3812863) were associated with BE (P < 0.05, Table 2). Three
variants of Cdx1 were associated with BE after Bonferroni correction. Several SNP variants,
including the significant SNPs, significantly interacted with the other BE risk factors and
showed an increased association with BE among subjects possessing both the risk factor and
the SNP variant after Bonferroni correction (Table 3).
Ten Cdx1 haplotypes and eight Cdx2 haplotypes were observed. One of the Cdx1 haplotypes
(GAGGA) was significantly associated with BE (OR 2.27, 95% CI 1.14–4.54, P = 0.02)
(Table 4). Additionally, haplotypes of Cdx1 interacted with male sex significantly (P =
0.0068) (Table 5).
For SNPs rs9257809 and rs9936833, no significant association with BE was observed
(Table 2). However, the wild-type A allele of rs9257809 and the mutant C allele of
rs9936833 showed significant interactions with risk factors including male, older age and
hernia (Table 3).
Discussion
This study is a pilot study to assess the association between SNPs of Cdx1 and Cdx2 and
BE. Based on clinical data, BE population was older and having more hiatal hernia and male
subjects than GERD controls (Table 1). Five SNPs and 1 haplotype of Cdx1 and Cdx2 were
associated with BE adjusted for sex, age and hiatal hernia (Table 2 and Table 4).
Significantly positive interactions between SNP variants and these risk factors were also
observed (Table 3).
Two SNPs (rs4769585 and rs3812863) and one haplotype of Cdx2 were significantly
associated with BE. Although these SNPs are located within 7.2-kb and 1.9-kb 5′-flanking
regions, respectively, it is not clear whether they may impact gene expression or functions.
Expression of Cdx2 is known to be regulated by promoter methylation [10] and NF-κB [13,
19]. Treatment of human esophageal epithelial cells with acid or bile partially demethylates
the Cdx2 CpG island (−1,769 bp to −1,363 bp) and markedly activates its expression [10].
However, this regulatory mechanism by promoter methylation was not reproduced in
another independent study. Use of different cell lines may contribute to the discrepancy [10,
13]. For NF-κB, there is a stepwise increased activity in human GERD and BE [20].
Activation of NF-κB induces Cdx2 expression in human gastroesophageal junction
adenocarcinoma cells [21]. Recently, two independent studies demonstrated that NF-κB
binding sites (−103 bp to −82 bp and −22 bp to −1 bp) in the Cdx2 promoter were
responsible for the bile acid-induced activation [13, 19].
Genetic variants may explain differential expression of Cdx2 human subjects with
gastroesophageal reflux. Cdx2 expression was found in esophageal squamous epithelium in
6 of 19 biopsy specimens from subjects with GERD and BE, but in none of 40 GERD
subjects without BE [22]. Acid and bile salts induce Cdx2 expression in esophageal
squamous cells from subjects with BE, but not in those cells from GERD subjects without
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BE [13]. One SNP (rs3812863) in Cdx2 promoter occurred in the binding site of forkhead
box protein P1, which is a transcriptional repressor and plays an important role in lung and
esophageal development [23]. Further studies are needed to identify genetic variants in the
promoter region which may in part dictate Cdx2 expression in esophageal epithelial cells.
Three SNPs (rs3776082, rs717746 and rs3776083) and one haplotype (GAGGA) of Cdx1
were significantly associated with BE. Rs3776082 is located in the 2.3-kb 5′-flanking
region, rs717746 in intron 1, and rs3776083 in the 3′-flanking region. Similar to Cdx2, the
5′UTR region of Cdx1 has at least four potential NF-κB subunit binding sites through which
NF-κB subunits may activate Cdx1 expression directly [24]. In fact, transgenic expression of
the nucleotides −15,601 to +68 of Cdx1 gene was restricted to the intestinal epithelium,
suggesting that this region contains intestine-specific enhancers, which are short regions of
DNA that can be bound by transcription factors to enhance transcription levels of intestinal
genes [16].
Consistent with previous results, older age (≥50 years), male sex and hiatal hernia were
associated with BE in this study [25, 26]. Many SNPs in this study significantly positively
interacted with these risk factors (P < 0.05, Table 3). In addition to SNP variants, Cdx1
haplotypes also significantly interacted with sex (P < 0.01).
In addition to Caucasian subjects, 41 African-Americans were enrolled in this study,
including 1 BE, 5 EE and 35 ERD. In our preliminary analysis including race as an
additional covariate, Caucasian race was very significantly associated with BE (P < 0.05,
data not shown). Association analysis with SNPs was not performed due to the small sample
size and imbalanced data set.
Recently, the first genome-wide association study on BE was reported [17]. Variants at two
loci were associated with BE: chromosome 6p21, rs9257809 (Pcombined = 4.09 × 10−9; OR =
1.21, 95%CI =1.13–1.28) and chromosome 16q24, rs9936833 (Pcombined = 2.74 × 10−10;
OR = 1.14, 95% CI = 1.10–1.19). However, no significant association with BE was
observed in this study (Table 2), with the exception of marked interaction between the wild-
type A allele of rs9257809 and the mutant C allele of rs9936833 and risk factors (Table 3),
indicating the complex genetic susceptibility to BE. We speculate that different ethnic or
geographic populations may account for such discrepancy.
Several limitations of our work deserve mention. Our study population was predominantly
Caucasian. While previous data on BE prevalence similarly indicate an overwhelming
preponderance in Caucasians, the generalizability of our data is limited. Secondly, subjects
were not required to stop taking acid suppressive medications to participate in the trial. This
likely caused some patients who would have otherwise been categorized as EE to become
ERD. The logistical problems with manipulating subjects’ medications in advance of their
enrollment in the study, as well as the ethical issues involved in stopping acid-suppressive
medications in subjects with BE, made stopping acid suppression untenable. Thirdly, BE
group was significantly older and having more male subjects and hiatal hernia than GERD
group. Therefore our study may potentially identify correlations between these risk factors
and BE, instead of causative risk. Fourthly, there is a small chance that the controls may
develop BE over time. This may impact our findings to a certain extent. Lastly, this study
has a relatively small sample size and is prone to type II error. Nevertheless, these novel
findings are preliminary and must be confirmed in subsequent studies with larger cohorts.
We are currently recruiting a confirmation cohort for an expression quantitative trait loci
(eQTL) study to associate these SNPs and haplotypes with gene expression [27]. North
Carolina has a relatively high African-American population, and recruitment of more
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African-American patients will allow us to further understand the potential contribution of
genetic variants in racial disparity of BE [28].
In conclusion, 5 SNPs and 1 haplotype of Cdx1 and Cdx2 were significantly associated with
BE. Significant interactions were observed between SNPs and other risk factors.
Acknowledgments
Grant support:
This study was supported by NIH/NCI U54 CA156735 and a gift from the Dave Brumitt Foundation for Gastric
and Esophageal Cancer Research.
We thank Dr. Jason Luo, Mammalian Genotyping Core, Lineberger Comprehensive Cancer Center, University of
North Carolina at Chapel Hill, for his technical assistance.
References
1. Malfertheiner P, Nocon M, Vieth M, et al. Evolution of gastro-oesophageal reflux disease over 5
years under routine medical care--the ProGERD study. Aliment Pharmacol Ther. 2012; 35:154–164.
[PubMed: 22070159]
2. Ronkainen J, Talley NJ, Storskrubb T, et al. Erosive esophagitis is a risk factor for Barrett’s
esophagus: a community-based endoscopic follow-up study. Am J Gastroenterol. 2011; 106:1946–
1952. [PubMed: 21946284]
3. Gelfand MD. Barrett esophagus in sexagenarian identical twins. J Clin Gastroenterol. 1983; 5:251–
253. [PubMed: 6683290]
4. Orloff M, Peterson C, He X, et al. Germline mutations in MSR1, ASCC1, and CTHRC1 in patients
with Barrett esophagus and esophageal adenocarcinoma. JAMA. 2011; 306:410–419. [PubMed:
21791690]
5. Moons LM, Kusters JG, van Delft JH, et al. A pro-inflammatory genotype predisposes to Barrett’s
esophagus. Carcinogenesis. 2008; 29:926–931. [PubMed: 18192685]
6. Kala Z, Dolina J, Marek F, Izakovicova Holla L. Polymorphisms of glutathione S-transferase M1,
T1 and P1 in patients with reflux esophagitis and Barrett’s esophagus. J Hum Genet. 2007; 52:527–
534. [PubMed: 17476458]
7. McElholm AR, McKnight AJ, Patterson CC, Johnston BT, Hardie LJ, Murray LJ. A population-
based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia,
adenocarcinoma sequence. Gastroenterology. 2010; 139:204–212. [PubMed: 20403354]
8. Chen H, Fang Y, Tevebaugh W, Orlando RC, Shaheen NJ, Chen X. Molecular mechanisms of
Barrett’s esophagus. Dig Dis Sci. 2011; 56:3405–3420. [PubMed: 21984436]
9. Groisman GM, Amar M, Meir A. Expression of the intestinal marker Cdx2 in the columnar-lined
esophagus with and without intestinal (Barrett’s) metaplasia. Mod Pathol. 2004; 17:1282–1288.
[PubMed: 15167938]
10. Liu T, Zhang X, So CK, et al. Regulation of Cdx2 expression by promoter methylation, and effects
of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells.
Carcinogenesis. 2007; 28:488–496. [PubMed: 16990345]
11. Eda A, Osawa H, Yanaka I, et al. Expression of homeobox gene CDX2 precedes that of CDX1
during the progression of intestinal metaplasia. J Gastroenterol. 2002; 37:94–100. [PubMed:
11871772]
12. Mutoh H, Sakurai S, Satoh K, et al. Cdx1 induced intestinal metaplasia in the transgenic mouse
stomach: comparative study with Cdx2 transgenic mice. Gut. 2004; 53:1416–1423. [PubMed:
15361487]
13. Huo X, Zhang HY, Zhang XI, et al. Acid and bile salt-induced CDX2 expression differs in
esophageal squamous cells from patients with and without Barrett’s esophagus. Gastroenterology.
2010; 139:194–203. [PubMed: 20303354]
Ren et al. Page 6













14. Crawford DC, Nickerson DA. Definition and clinical importance of haplotypes. Annu Rev Med.
2005; 56:303–320. [PubMed: 15660514]
15. Hinoi T, Loda M, Fearon ER. Silencing of CDX2 expression in colon cancer via a dominant
repression pathway. J Biol Chem. 2003; 278:44608–44616. [PubMed: 12947088]
16. Rankin EB, Xu W, Silberg DG, Suh E. Putative intestine-specific enhancers located in 5′ sequence
of the CDX1 gene regulate CDX1 expression in the intestine. Am J Physiol Gastrointest Liver
Physiol. 2004; 286:G872–880. [PubMed: 14715525]
17. Su Z, Gay LJ, Strange A, Palles C, et al. Common variants at the MHC locus and at chromosome
16q24.1 predispose to Barrett’s esophagus. Nat Genet. 2012; 44:1131–1136. [PubMed: 22961001]
18. Solé X, Guinó E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association
studies. Bioinformatics. 2006; 22:1928–1929. [PubMed: 16720584]
19. Kazumori H, Ishihara S, Rumi MA, Kadowaki Y, Kinoshita Y. Bile acids directly augment caudal
related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett’s epithelium. Gut.
2006; 55:16–25. [PubMed: 16118348]
20. O’Riordan JM, Abdel-latif MM, Ravi N, et al. Proinflammatory cytokine and nuclear factor kappa-
B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the
esophagus. Am J Gastroenterol. 2005; 100:1257–1264. [PubMed: 15929754]
21. Debruyne PR, Witek M, Gong L, et al. Bile acids induce ectopic expression of intestinal guanylyl
cyclase C through nuclear factor-kappaB and Cdx2 in human esophageal cells. Gastroenterology.
2006; 130:1191–1206. [PubMed: 16618413]
22. Moons LM, Bax DA, Kuipers EJ, et al. The homeodomain protein CDX2 is an early marker of
Barrett’s oesophagus. J Clin Pathol. 2004; 57:1063–1068. [PubMed: 15452161]
23. Shu W, Lu MM, Zhang Y, et al. Foxp2 and Foxp1 cooperatively regulate lung and esophagus
development. Development. 2007; 134:1991–2000. [PubMed: 17428829]
24. Wong NACS, Wilding J, Bartlett S, et al. CDX1 is an important molecular mediator of Barrett’s
metaplasia. Proc Natl Acad Sci USA. 2005; 102:7565–7570. [PubMed: 15894614]
25. Ford AC, Forman D, Reynolds PD, Cooper BT, Moayyedi P. Ethnicity, gender, and socioeconomic
status as risk factors for esophagitis and Barrett’s esophagus. Am J Epidemiol. 2005; 162:454–
460. [PubMed: 16076833]
26. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Hiatal hernia and acid reflux frequency predict
presence and length of Barrett’s esophagus. Dig Dis Sci. 2002; 47:256–264. [PubMed: 11855539]
27. Seo JH, Li Q, Fatima A, et al. Deconvoluting complex tissues for expression quantitative trait
locus-based analyses. Philos Trans R Soc Lond B Biol Sci. 201310.1098/rstb.2012.0363
28. Wang A, Mattek NC, Holub JL, Lieberman DA, Eisen GM. Prevalence of complicated
gastroesophageal reflux disease and Barrett’s esophagus among racial groups in a multi-center
consortium. Dig Dis Sci. 2009; 54:964–971. [PubMed: 19255852]
Ren et al. Page 7

























Ren et al. Page 8
Table 1
Characteristics of clinical subjects in this study
Characteristic BE (n = 109) ERD (n = 192) EEE (n = 31) GERD (ERD + EE) (n = 223)
Sex, male * 72 (66.1%) 77 (40.1%) 15 (48.4%) 92 (41.3%)
Hiatal hernia * 70 (64.2%) 76 (39.6%) 21 (67.7%) 97 (43.5%)
Age (years) *
 ≥50 87 (79.8%) 103 (53.6%) 21 (67.7%) 124 (55.6%)
 Range 28 – 81 19 – 80 20 – 74 19 – 80
 Mean ± SD 59.2 ± 10.8 51.4 ± 13.9 52.6 ± 12.8 51.5 ± 13.7
*
Significant difference between GERD and BE according to Fisher’s exact test (P < 0.001).
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